Disclosure Of Entity's Operating Segments [Text Block]

Affluent Medical - Filing #2810675

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
- EUR
- EUR
Depreciation and amortisation expense
2 413 EUR
2 450 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
- EUR
- EUR
Tax expense (income)
150,000 EUR
173,000 EUR
Profit (loss) before tax
15 803 EUR
15 400 EUR
Profit (loss)
15 653 EUR
- EUR
15 653 EUR
- EUR
- EUR
- EUR
15 653 EUR
- EUR
- EUR
15 227 EUR
15 227 EUR
- EUR
- EUR
15 227 EUR
- EUR
- EUR
Assets
56 676 EUR
60 020 EUR
Investments accounted for using equity method
- EUR
- EUR
Cash flows from (used in) operating activities
12 054 EUR
11 081 EUR
Cash flows from (used in) investing activities
184,000 EUR
146,000 EUR
Cash flows from (used in) financing activities
11 316 EUR
2 401 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.